數量：1供應商：BPSBioscience細胞類型：穩轉細胞系品系：Jurkat(cloneE6-1)
- 數量：
1
- 供應商：
BPS Bioscience
- 細胞類型：
穩轉細胞系
- 品系：
Jurkat (clone E6-1), human T lymphoblast, suspension
- 組織來源：
/
- 相關疾病：
多種
- 物種來源：
human
- 免疫類型：
多種
- 器官來源：
無
- 運輸方式：
干冰
- 年限：
10
- 生長狀態：
良好
- CAS號：
無
- 英文名：
TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line
- 注冊證號：
/
- 規格：
2管
This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells to generate the TCR Knockout NFAT Luciferase Reporter Jurkat cell Line (BPS Bioscience #78556). These TCR knockout cells were used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity.
化工儀器網